Medical management of gastric cancer: A 2014 update

Por Elimova, Elena, Shiozaki, Hironori, Wadhwa, Roopma, Sudo, Kazuki, Chen, Qiongrong, Estrella, Jeannelyn S, Blum, Mariela A, Badgwell, Brian, Das, Prajnan, Song, Shumei, Ajani, Jaffer A
Publicado em 2014

Distribution and timing of distant metastasis after local therapy in large cohort of patients with esophageal and esophagogastric junction cancer

Por Shiozaki, Hironori, Sudo, Kazuki, Xiao, Lianchun, Wadhwa, Roopma, Elimova, Elena, Hofstetter, Wayne L., Skinner, Heath D., Lee, Jeffrey H., Weston, Brian, Bhutani, Manoop S., Blum, Mariela A., Maru, Dipen M., Ajani, Jaffer A.
Publicado em 2014

A Nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer

Por Hayashi, Yuki, Xiao, Lianchun, Suzuki, Akihiro, Blum, Mariela A., Sabloff, Bradley, Taketa, Takashi, Maru, Dipen M., Welsh, James, Lin, Steven H., Weston, Brian, Lee, Jeffrey H., Bhutani, Manoop S., Hofstetter, Wayne L., Swisher, Stephen G., Ajani, Jaffer A.
Publicado em 2012

Early Versus Delayed Therapy of Advanced Gastric Cancer Patients – Does it make a difference?

Por Elimova, Elena, Shiozaki, Hironori, Slack, Rebecca, Chen, Hsiang-Chun, Wadhwa, Roopma, Sudo, Kazuki, Charalampakis, Nikolaos, Hiremath, Adarsh, Estrella, Jeannelyn, Matamoros, Aurelio, Sagebiel, Tara, Das, Prajnan, Rogers, Jane E., Garris, Jeana, Blum, Mariela A., Badgwell, Brian, Ajani, Jaffer A.
Publicado no Oncology (2015)

Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience

Por Al-Shamsi, Humaid O., Fahmawi, Yazan, Dahbour, Ibrahim, Tabash, Aziz, Rogers, Jane E., Mares, Jeannette Elizabeth, Blum, Mariela A., Estrella, Jeannelyn, Matamoros, Aurelio, Sagebiel, Tara, Devine, Catherine E., Badgwell, Brian D., Lin, Quan D., Das, Prajnan, Ajani, Jaffer A.
Publicado no J Gastrointest Oncol (2016)

Geographic Distribution of Regional Metastatic Nodes Affects Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma

Por Shiozaki, Hironori, Slack, Rebecca, Sudo, Kazuki, Elimova, Elena, Wadhwa, Roopma, Chen, Hsiang-Chun, Skinner, Heath D., Komaki, Ritsuko, Lee, Jeffrey H., Weston, Brian, Bhutani, Manoop S., Blum, Mariela A., Rogers, Jane E., Maru, Dipen M., Hofstetter, Wayne L., Ajani, Jaffer A.
Publicado no Oncology (2015)

Initial Standardized Uptake Value (iSUV) of Positron Emission Tomography Influences Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively

Por Charalampakis, Nikolaos, Xiao, Lianchun, Elimova, Elena, Wadhwa, Roopma, Shiozaki, Hironori, Shimodaira, Yusuke, Blum, Mariela A., Planjery, Venkatram, Rogers, Jane E., Matamoros, Aurelio, Sagebiel, Tara, Das, Prajnan, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Estrella, Jeannelyn S., Badgwell, Brian D., Ajani, Jaffer A.
Publicado no Oncology (2015)

Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies

Por Sudo, Kazuki, Taketa, Takashi, Correa, Arlene M., Campagna, Maria-Claudia, Wadhwa, Roopma, Blum, Mariela A., Komaki, Ritsuko, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Skinner, Heath D., Maru, Dipen M., Rice, David C., Swisher, Stephen G., Hofstetter, Wayne L., Ajani, Jaffer A.
Publicado em 2013

18F-FDG PET/CT as Predictive of Response after Chemoradiation in Esophageal Cancer Patients

Por Elimova, Elena, Wang, Xuemei, Etchebehere, Elba, Shiozaki, Hironori, Shimodaira, Yusuke, Wadhwa, Roopma, Planjery, Venkatram, Charalampakis, Nikolaos, Blum, Mariela A., Hofstetter, Wayne, Lee, Jeff H., Weston, Brian R., Bhutani, Manoop S., Rogers, Jane E., Maru, Dipen, Skinner, Heath D., Macapinlac, Homer A., Ajani, Jaffer A.
Publicado no Eur J Cancer (2015)

Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation

Por Taketa, Takashi, Correa, Arlene M., Suzuki, Akihiro, Blum, Mariela A., Chien, Pamela, Lee, Jeffrey H., Welsh, James, Lin, Steven H., Maru, Dipen M., Erasmus, Jeremy J., Bhutani, Manoop S., Weston, Brian, Rice, David C., Vaporciyan, Ara A., Hofstetter, Wayne L., Swisher, Stephen G., Ajani, Jaffer A.
Publicado em 2012

Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer

Por Sudo, Kazuki, Xiao, Lianchun, Wadhwa, Roopma, Shiozaki, Hironori, Elimova, Elena, Taketa, Takashi, Blum, Mariela A., Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Ross, William A., Komaki, Ritsuko, Rice, David C., Swisher, Stephen G., Hofstetter, Wayne L., Maru, Dipen M., Skinner, Heath D., Ajani, Jaffer A.
Publicado em 2014

The proportion of signet ring cell component in patients with localized gastric adenocarcinoma correlates with the degree of response to preoperative chemoradiation

Por Charalampakis, Nikolaos, Nogueras González, Graciela M., Elimova, Elena, Wadhwa, Roopma, Shiozaki, Hironori, Shimodaira, Yusuke, Blum, Mariela A., Rogers, Jane E., Harada, Kazuto, Matamoros, Aurelio, Sagebiel, Tara, Das, Prajnan, Minsky, Bruce D., Lee, Jeffrey H., Weston, Brian, Bhutani, Manoop S., Estrella, Jeannelyn S., Badgwell, Brian D., Ajani, Jaffer A.
Publicado no Oncology (2016)

Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients After Chemoradiation: Its Clinical Implications

Por Neishaboori, Nastaran, Wadhwa, Roopma, Nogueras-González, Graciela M., Elimova, Elena, Shiozaki, Hironori, Sudo, Kazuki, Charalampakis, Nikolaos, Hiremath, Adarsh, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Blum, Mariela A., Rogers, Jane E., Garris, Jeana L., Rice, David C., Komaki, Ritsuko, Swisher, Stephen G., Skinner, Heath D., Hofstetter, Wayne L., Ajani, Jaffer A.
Publicado no Oncology (2015)